An Overview on Oncolytic Viruses as Cancer Therapy
Journal Title: International Journal of Cancer Studies & Research (IJCR) - Year 2017, Vol 6, Issue 2
Abstract
The current regimen of cancer therapy (chemotherapy and radiotherapy) suffers with disadvantages such as narrow therapeutic index that further facilitate tumor evolves drug resistance and severe side-effects. Oncolytic viruses are therapeutically useful anticancer viruses that will selectively infect and damage cancerous tissues without causing harm to the normal tissues. Many naturally occurring Oncolytic viruses have a preferential tropism to tumor or associated endothelial cells and others are genetically engineered to change their cellular or organ tropism toward cancer. Antitumor effect of Oncolytic viruses is either by locale cell death or by initiation of the systemic immune response against tumor. Oncolytic Adenovirus, Herpes Simplex Virus, Newcastle Disease Virus, and Reoviruse are representative of Oncolytic viruses that have potential to lysis tumor. The effects of the host immune response on the efficacy of Oncolytic viruses are complex. But, using of carrier cells as delivery vehicles could hide the viral antigen from antibodies and complements. Oncolytic viruses have been combined with many cancer therapies to increase response against cancer. Since many forms of canine or feline neoplasms resemble to humane counterpart. So, oncologists believe that Oncolytic virotherapy could soon be a reality in veterinary medicine.
Authors and Affiliations
Demisse Habtamu
Keywords
Related Articles
- EP ID EP322710
- DOI 10.19070/2167-9118-1700023
- Views 106
- Downloads 0
Modeling and Simulation of EGF-CSF-1 pathway to Investigate Glioma - Macrophage Interaction in Brain Tumors
Glioblastoma multiform (GBM) is one of the most lethal forms of brain cancers. The biggest difficulties for diagnostics and treatment of GBM underlie in its dynamic and complex macro and microenvironment. Glioma cells, s...
Are there any Dermoscopic Signs of Primary Cutaneous Follicular Center B-cell Lymphoma?
Cutaneous follicular center B-cell lymphoma is an indolent tumor that arise on head or neck. Histology by immunotyping with monoclonal antibodies in frozen or paraffin - embedded tissue is necessary for diagnosis. The tu...
20-HETE Mimetics or Inhibitors in the Treatment of Cancer Patients with Sepsis and Septic Shock
Patients with a variety of malignancies have a greater tendency to acquire infections than patients with non-malignant disorders. Sepsis and septic shock are common complications in patients with cancer. As the most comm...
Therapeutic Potential of Tumor Suppressors in Treating Breast Cancer
Purpose: Tumor suppressor genes participate in a variety of critical and highly conserved cell functions, including regulation of the cell cycle and apoptosis, differentiation, surveillance of genomic integrity and repai...
Efficacy of 0.5% 5-Fluorouracil Cream and Absence of Undesirable Secondary Effects in the Treatment of Grade III Actinic Keratoses in the Presence of 5% Dobesilate
Background: 5-Fluorouracil (5-FU) has been a standardized topical treatment for actinic keratosis (AK) lesions, however to treat deep and hyperkeratotic AK a long treatment time is often required. Furthermore, in grade I...